Susana Barriga
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Cancer Research top 1%
- Genetics top 1%
- Molecular Biology
- Co-authors
- Masakazu ToiMartin FrenzelJoohyuk SohnNawel BourayouMatthew P. GoetzNorikazu MasudaGeorge W. SledgeTammy Forrester
- Topics
- Advanced Breast Cancer Therapies (22 papers)HER2/EGFR in Cancer Research (11 papers)Cancer-related Molecular Pathways (7 papers)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Susana Barriga
25 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 3.3k
- Oncology 2.9k
- Cancer Research 1.2k
- Genetics 920
- Molecular Biology 279
Countries citing papers authored by Susana Barriga
This map shows the geographic impact of Susana Barriga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Barriga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Barriga more than expected).
Fields of papers citing papers by Susana Barriga
This network shows the impact of papers produced by Susana Barriga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Barriga. The network helps show where Susana Barriga may publish in the future.
Co-authorship network of co-authors of Susana Barriga
This figure shows the co-authorship network connecting the top 25 collaborators of Susana Barriga. A scholar is included among the top collaborators of Susana Barriga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Barriga. Susana Barriga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 21 | |
| 4 | 105 | |
| 5 | MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerbreakdown → | 407 |
| 6 | 154 | |
| 7 | The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2breakdown → | 590 |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancerbreakdown → | 1125 |
| 12 | MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapybreakdown → | 1103 |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 1 | |
| 16 | 10 | |
| 17 | 12 | |
| 18 | 16 | |
| 19 | 23 | |
| 20 | 10 |
About Susana Barriga
Susana Barriga is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 26 papers that have together received 3.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (22 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Oncology (2.9k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Genetics (920 citations). Susana Barriga has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Masakazu Toi, Martin Frenzel, Joohyuk Sohn, Nawel Bourayou, Matthew P. Goetz, Norikazu Masuda, George W. Sledge, Tammy Forrester, Angelo Di Leo and Peter A. Kaufman. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.